| 000 | 00849 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512004058.0 | ||
| 264 | 0 | _c19900309 | |
| 008 | 199003s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.299.6714.1524-a _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFish, D R | |
| 245 | 0 | 0 |
_aRisks and benefits of antimalarial drugs. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cDec 1989 |
||
| 300 |
_a1524 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAntimalarials _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aSeizures _xchemically induced |
| 650 | 0 | 4 | _aTravel |
| 700 | 1 | _aEspir, M L | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 299 _gno. 6714 _gp. 1524 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.299.6714.1524-a _zAvailable from publisher's website |
| 999 |
_c2520864 _d2520864 |
||